NIH-funded research NIH-funded research

Enhancing pathogen and AMR detection with a new sequencing instrument

Official title: Enhancing Sequencing Capacity for AMR Surveillance and Emerging Pathogen Detection through Acquisition of the Illumina MiSeq i100

Funded at University of Nebraska Lincoln · NIH-11527014 · Data updated 2026-11-12

A veterinary lab is getting a high-throughput sequencing machine to help detect drug-resistant bacteria and emerging pathogens in animals and food, improving public health readiness.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Lincoln
NIH-funded
Lab location1 site (Lincoln, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2027
Funding year2026
Award (this year)$60,000
NIH project number1U18FD008916-01
Project IDNIH-11527014 on NIH RePORTER

Who could benefit from this research

Could help

Ideal when animal health professionals need rapid, high-quality genomic data to track pathogens or AMR trends during outbreaks or routine surveillance.

Less likely to help

Direct patient involvement is unlikely; primarily serves animal health and food safety applications.

What this research studies

This grant funds the purchase of a Illumina MiSeq i100 to boost whole-genome sequencing at the Nebraska Veterinary Diagnostic Center. The goal is to increase the speed, accuracy, and volume of genomic data available for veterinary pathogens, antimicrobial resistance monitoring, and One Health investigations. The improved sequencing capacity should enhance diagnostic support during animal disease outbreaks and help inform safer food safety practices. The project focuses on integrating the new instrument into existing workflows and expanding data output for a wider range of samples.

Why it matters

Potential benefit: If successful, the project could lead to faster outbreak detection and better guidance to protect animal and human health.

How similar studies have gone: Similar sequencing upgrades in veterinary labs have improved outbreak response and AMR monitoring, though throughput gains depend on implemented workflows.

Where this research is happening

  • University of Nebraska Lincoln
    Lincoln, United States
    Active

Researchers

  • Principal investigator: Loy, Duan S — University of Nebraska Lincoln
  • Study coordinator: Loy, Duan S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.